Reduction in circulating pro-angiogenic and pro-inflammatory factors is related to improved outcomes in patients with advanced pancreatic cancer treated with gemcitabine and intravenous omega-3 fish oil.
about
Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosisMolecular Targeted Intervention for Pancreatic CancerIntravenous ω-3 Fatty Acids Plus Gemcitabine.Gemcitabine diphosphate choline is a major metabolite linked to the Kennedy pathway in pancreatic cancer models in vivo.Omega-3 polyunsaturated fatty acids and cancer: lessons learned from clinical trials.Synthesis, Characterization, and In Vitro and In Vivo Evaluations of 4-(N)-Docosahexaenoyl 2', 2'-Difluorodeoxycytidine with Potent and Broad-Spectrum Antitumor Activity.CAF cellular glycolysis: linking cancer cells with the microenvironment.Anti-cancer Mechanism of Docosahexaenoic Acid in Pancreatic Carcinogenesis: A Mini-review.How plausible is the use of dietary n-3 PUFA in the adjuvant therapy of cancer?Preclinical Evaluation of the Short-Term Toxicity of 4-(N)-Docosahexaenoyl 2´, 2´- Difluorodeoxycytidine (DHA-dFdC).Targeting pancreatic cancer using a combination of gemcitabine with the omega-3 polyunsaturated fatty acid emulsion, Lipidem™.Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancer
P2860
Q26741263-A53B2671-158C-470A-B685-A9CDB25EE6C8Q26798453-1C956077-783B-4049-9A9D-61CB02D404FBQ33424793-031E9CA5-9B0F-4E4F-9F4F-1202B5DDAE0BQ33918107-EE4CCB73-BF25-419A-8E88-EB18BCE88574Q38557891-8EEB97CE-BE1C-476D-B1DD-9EB702CAC2FDQ38799790-329EF060-E55E-4634-8CDD-2DA27BEEBDAFQ38807630-0FB9D85F-1CAC-47F3-AC0E-B8A96ECDACB5Q39223483-54E5AEBC-FC9A-4715-885D-0DFB7927F430Q39771420-7E13750F-65D2-4B5C-9DD1-65479FD1B647Q52779258-89E0C0F1-A9F7-49B4-AE17-021A4AFC10B7Q54232104-63D0E2EF-B83D-4C97-96F2-9E24BDB97FA5Q57115352-7AA3E3EC-EB30-409B-BF95-061217CCFDB3
P2860
Reduction in circulating pro-angiogenic and pro-inflammatory factors is related to improved outcomes in patients with advanced pancreatic cancer treated with gemcitabine and intravenous omega-3 fish oil.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Reduction in circulating pro-a ...... intravenous omega-3 fish oil.
@en
type
label
Reduction in circulating pro-a ...... intravenous omega-3 fish oil.
@en
prefLabel
Reduction in circulating pro-a ...... intravenous omega-3 fish oil.
@en
P2093
P2860
P356
P1476
Reduction in circulating pro-a ...... d intravenous omega-3 fish oil
@en
P2093
Ali Arshad
Matthew S Metcalfe
Wen Y Chung
William Steward
P2860
P304
P356
10.1111/HPB.12002
P577
2012-11-22T00:00:00Z